New hope for type 1 diabetes: can empagliflozin or semaglutide help control blood sugar?
NCT ID NCT06762314
First seen Mar 14, 2026 · Last updated May 22, 2026 · Updated 12 times
Summary
This study is for overweight or obese adults with type 1 diabetes whose blood sugar is not well controlled with insulin alone. Researchers want to see if adding empagliflozin or semaglutide to insulin can lower blood sugar levels over 3 months. About 105 participants will be randomly assigned to one of the two drugs or a placebo. The goal is to find a safer, more effective way to manage diabetes without causing weight gain or dangerous low blood sugar.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for DIABETES are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Tanta Unuversity
RECRUITINGTanta, 31527, Egypt
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
Conditions
Explore the condition pages connected to this study.